^
BIOMARKER:

CD276 overexpression

i
Other names: CD276, CD276 Molecule, CD276 Antigen, B7 Homolog 3, B7-H3, B7RP-2
Entrez ID:
Related biomarkers:
CD276 overexpression
Solid Tumor
DS-7300
Sensitive: C3 – Early Trials
CD276 overexpression
Prostate Cancer
DS-7300
Sensitive: C3 – Early Trials
CD276 overexpression
Small Cell Lung Cancer
DS-7300
Sensitive: C3 – Early Trials
CD276 overexpression
NSCLC
DS-7300
Sensitive: C3 – Early Trials
CD276 overexpression
Esophageal Squamous Cell Carcinoma
DS-7300
Sensitive: C3 – Early Trials
CD276 overexpression
NSCLC
trametinib
Sensitive: D – Preclinical
CD276 overexpression
Multiple Myeloma
ruxolitinib
Sensitive: D – Preclinical
CD276 overexpression
SCCHN
MGC018
Sensitive: D – Preclinical
CD276 overexpression
Triple Negative Breast Cancer
B7H3-targeted CAR-T immunotherapy
Sensitive: D – Preclinical
CD276 overexpression
Solid Tumor
GTB-5550
Sensitive: D – Preclinical